Peng Chen will be speaking at the 9th SABPA Pacific Forum that will be held on Saturday Oct. 5, 2013 at the Institute of the Americas, UCSD. As one of the flagship annual conferences organized by SABPA, Pacific Forum (PF) draws about 300 life sciences professionals from across the Pacific every year. The main themes of this year’s conference will include 1) cross-border collaborations in the pharmaceutical and biotech field that have effectively integrated resources to fuel innovative R&D and business in the Pacific Rim, and 2) recent trends in applying genomic technologies to improving human healthcare. Senior leaders from the R&D divisions of pharmaceutical and biotech companies, international IP experts, world-renowned researchers from universities and academic institutions, and executives of organizations from the Asia Pacific region will share their insights on a variety of exciting topics at this event.

Mr. Chen’s topic will be on, “Implications of Myriad on IP Protection for Personalized Medicine and Protecting IP in US and China.”

For more information, click here.